アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/26 | 1,482 | 1,506 | 1,446 | 1,506 | +51 | +3.5% | 13,564,300 |
2024/04/25 | 1,470.5 | 1,484.5 | 1,453 | 1,455 | -14 | -1% | 8,318,300 |
2024/04/24 | 1,464 | 1,485 | 1,463 | 1,469 | -22.5 | -1.5% | 10,715,000 |
2024/04/23 | 1,477.5 | 1,506 | 1,477.5 | 1,491.5 | +15.5 | +1.1% | 6,786,600 |
2024/04/22 | 1,497.5 | 1,509 | 1,474.5 | 1,476 | -4.5 | -0.3% | 8,068,600 |
2024/04/19 | 1,486 | 1,495.5 | 1,467.5 | 1,480.5 | +15 | +1% | 7,909,200 |
2024/04/18 | 1,466.5 | 1,477 | 1,463 | 1,465.5 | -1 | -0.1% | 6,445,400 |
2024/04/17 | 1,454.5 | 1,489 | 1,448 | 1,466.5 | +15 | +1% | 9,854,500 |
2024/04/16 | 1,446.5 | 1,461.5 | 1,426 | 1,451.5 | +5.5 | +0.4% | 17,781,200 |
2024/04/15 | 1,506.5 | 1,524.5 | 1,436 | 1,446 | -125 | -8% | 30,231,300 |
2024/04/12 | 1,576.5 | 1,585 | 1,569 | 1,571 | -13.5 | -0.9% | 7,614,200 |
2024/04/11 | 1,567 | 1,587 | 1,565.5 | 1,584.5 | +10.5 | +0.7% | 7,450,600 |
2024/04/10 | 1,596 | 1,598.5 | 1,573 | 1,574 | -22 | -1.4% | 6,462,800 |
2024/04/09 | 1,590.5 | 1,602.5 | 1,590.5 | 1,596 | -0.5 | ±0% | 4,866,600 |
2024/04/08 | 1,610 | 1,610.5 | 1,590.5 | 1,596.5 | -6 | -0.4% | 5,212,600 |
2024/04/05 | 1,598 | 1,607 | 1,582.5 | 1,602.5 | -1 | -0.1% | 8,254,600 |
2024/04/04 | 1,628.5 | 1,631 | 1,603 | 1,603.5 | -17.5 | -1.1% | 7,907,800 |
2024/04/03 | 1,646 | 1,647 | 1,613.5 | 1,621 | -27.5 | -1.7% | 7,124,300 |
2024/04/02 | 1,638 | 1,652.5 | 1,634.5 | 1,648.5 | +7.5 | +0.5% | 6,014,900 |
2024/04/01 | 1,652 | 1,671 | 1,640.5 | 1,641 | -2.5 | -0.2% | 6,093,200 |
2024/03/29 | 1,638.5 | 1,663 | 1,635.5 | 1,643.5 | +18.5 | +1.1% | 8,612,400 |
2024/03/28 | 1,655 | 1,659.5 | 1,622 | 1,625 | -67.5 | -4% | 9,670,000 |
2024/03/27 | 1,685 | 1,696.5 | 1,677 | 1,692.5 | +18 | +1.1% | 12,397,500 |
2024/03/26 | 1,650 | 1,679.5 | 1,642 | 1,674.5 | +21 | +1.3% | 8,019,600 |
2024/03/25 | 1,676 | 1,676 | 1,653.5 | 1,653.5 | -18.5 | -1.1% | 7,191,500 |
2024/03/22 | 1,669 | 1,684 | 1,651.5 | 1,672 | -5 | -0.3% | 10,452,200 |
2024/03/21 | 1,661 | 1,679 | 1,653 | 1,677 | +30.5 | +1.9% | 10,254,800 |
2024/03/19 | 1,636.5 | 1,646.5 | 1,630 | 1,646.5 | +10.5 | +0.6% | 5,013,800 |
2024/03/18 | 1,626 | 1,642 | 1,622 | 1,636 | +21 | +1.3% | 6,715,400 |
2024/03/15 | 1,600 | 1,615.5 | 1,596 | 1,615 | +22 | +1.4% | 8,037,300 |
2024/03/14 | 1,584 | 1,600.5 | 1,578.5 | 1,593 | +9.5 | +0.6% | 5,628,000 |
2024/03/13 | 1,594 | 1,597 | 1,583.5 | 1,583.5 | -11 | -0.7% | 7,033,900 |
2024/03/12 | 1,610.5 | 1,610.5 | 1,573 | 1,594.5 | -3.5 | -0.2% | 6,782,500 |
2024/03/11 | 1,577 | 1,603 | 1,573.5 | 1,598 | +22.5 | +1.4% | 10,667,900 |
2024/03/08 | 1,567.5 | 1,581.5 | 1,551 | 1,575.5 | -23.5 | -1.5% | 18,824,400 |
2024/03/07 | 1,624.5 | 1,630.5 | 1,596 | 1,599 | -37.5 | -2.3% | 17,418,900 |
2024/03/06 | 1,636 | 1,650 | 1,626 | 1,636.5 | +0.5 | ±0% | 9,089,400 |
2024/03/05 | 1,662 | 1,670 | 1,635.5 | 1,636 | -45.5 | -2.7% | 11,389,100 |
2024/03/04 | 1,686 | 1,687 | 1,663 | 1,681.5 | +7 | +0.4% | 8,117,400 |
2024/03/01 | 1,656 | 1,679.5 | 1,655 | 1,674.5 | +23 | +1.4% | 7,094,100 |
2024/02/29 | 1,658.5 | 1,666 | 1,638.5 | 1,651.5 | -12.5 | -0.8% | 8,823,500 |
2024/02/28 | 1,665.5 | 1,674.5 | 1,658.5 | 1,664 | +5.5 | +0.3% | 5,539,400 |
2024/02/27 | 1,640 | 1,660 | 1,637 | 1,658.5 | -13 | -0.8% | 10,490,900 |
2024/02/26 | 1,655 | 1,678.5 | 1,649 | 1,671.5 | +22 | +1.3% | 9,134,600 |
2024/02/22 | 1,671 | 1,672.5 | 1,647.5 | 1,649.5 | -27.5 | -1.6% | 11,540,500 |
2024/02/21 | 1,688.5 | 1,691 | 1,675.5 | 1,677 | -8 | -0.5% | 5,663,400 |
2024/02/20 | 1,690 | 1,695.5 | 1,680.5 | 1,685 | +2.5 | +0.1% | 5,214,100 |
2024/02/19 | 1,678.5 | 1,690 | 1,670 | 1,682.5 | +7.5 | +0.4% | 5,396,400 |
2024/02/16 | 1,665 | 1,682 | 1,653 | 1,675 | +22.5 | +1.4% | 7,595,500 |
2024/02/15 | 1,670 | 1,670 | 1,639 | 1,652.5 | -13.5 | -0.8% | 5,805,600 |
251~
300
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 423,400円 | -1.1% | +75.3% | 4.72% | 29.00倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム